Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy

Deflazacort and prednisone/prednisolone are the current standard of care for patients with Duchenne muscular dystrophy (DMD) based on evidence that they improve muscle strength, improve timed motor function, delay loss of ambulation, improve pulmonary function, reduce the need for scoliosis surgery,...

Descripción completa

Detalles Bibliográficos
Autores principales: Biggar, W. Douglas, Skalsky, Andrew, McDonald, Craig M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398085/
https://www.ncbi.nlm.nih.gov/pubmed/35723111
http://dx.doi.org/10.3233/JND-210776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398085/
https://www.ncbi.nlm.nih.gov/pubmed/35723111
http://dx.doi.org/10.3233/JND-210776

Ejemplares similares